Biocryst Pharmaceuticals Inc Ratios

Ratios Dec2009 Dec2010 Dec2011 Dec2012 Dec2013 Dec2014
Profitability
Gross Margin 93.91%99.86%99.50%99.43%99.11%
EBT Margin -18.03%-54.27%-269.55%-145.79%-204.27%-372.40%
EBIT Margin -18.42%-55.08%-252.44%-128.89%-177.24%-336.35%
EBITDA Margin -18.42%-55.08%-290.25%-148.69%-173.86%-333.06%
Operating Margin -18.42%-55.08%-252.44%-128.89%-177.24%-336.35%
Net Margin -18.03%-54.27%-269.55%-145.79%-204.27%-372.40%
FCF Margin -22.55%-46.30%-164.47%-142.66%-153.25%-284.08%
Efficiency
Inventory Average 0.58M
Assets Average 95.83M69.82M53.15M92.87M
Equity Average 75.88M40.15M7.18M-0.79M37.25M
Invested Capital 86.27M65.50M14.81M-0.45M-1.13M75.64M
Asset Utilization Ratio 0.200.380.330.15
Leverage & Solvency
Interest Coverage Ratio -13.14-7.26-6.43-9.16
Debt to Equity 2.03-66.08-26.640.40
Debt Ratio 0.360.520.610.22
Equity Ratio 0.600.18-0.01-0.020.55
Times Interest Earned -13.14-7.26-6.43-9.16
Valuation
Enterprise Value 209.67M178.31M69.96M36.65M411.04M801.09M
Market Capitalization 250.80M232.25M111.68M72.25M449.09M873.86M
Return Ratios
Return on Sales -0.18%-0.54%-2.70%-1.46%-2.04%-3.72%
Return on Capital Employed -0.71%-0.64%-0.81%-1.29%
Return on Assets -0.55%-0.55%-0.67%-0.55%
Return on Equity -0.45%-1.32%-5.34%44.81%-1.36%